UK-14,304

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID1943
Ligand NameUK-14,304
PubMed Compound Id2435
StructureProduct Image
Molecular FormulaC11H10BrN5
Molecular Weight292.13
SMILESC1CN=C(N1)NC2=C(C3=NC=CN=C3C=C2)Br
Synonymsbrimonidine
59803-98-4
Bromoxidine
5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
brimonidina
brimonidinum
5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline
5-bromo-6-(imidazolin-2-ylamino)quinoxaline
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-
E6GNX3HHTE
UNII-E6GNX3HHTE
NSC-318825
BRN 0751629
CHEBI:3175
AGN-190342 FREE BASE
LK 14304-18
UK-1430418 FREE BASE
NSC 318825
UK14,304
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-, (S-(R*,R*))-2,3-dihydroxybutanedioate (1:1)
Brimodine
5-bromo-6-(imidazolidinylideneamino)quinoxaline
D11AX21
S01EA05
UK 14,304
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine
UK-14304
AGN 190342
UK 14304
MFCD00153878
MLS000069370
CHEMBL844
SMR000058355
DTXSID3045221
Brimonidine (INN)
NCGC00016069-09
UK 14304;AGN190342
BRIMONIDINE [INN]
UK 14304 (tartrate);AGN190342 (tartrate)
5-Bromo-N-(2-imidazolin-2-yl)-6-quinoxalinamine
DTXCID1025221
Brimonidine [INN:BAN]
CAS-59803-98-4
SR-01000000023
AGN-190342
UK14304
Brimonidine (Standard)
Tocris-0425
[3H]-UK14304
Opera_ID_612
Lopac-U-104
BRIMONIDINE [MI]
brimonidine (UK14304)
BRIMONIDINE [VANDF]
cid_2435
Lopac0_001216
SCHEMBL24670
BRIMONIDINE [WHO-DD]
GTPL520
MLS001076349
BIDD:GT0649
GTPL5386
BDBM34572
HY-B0659R
[3H]brimonidine (UK14304)
XYLJNLCSTIOKRM-UHFFFAOYSA-N
HMS3259P09
HMS3263D14
HMS3266O03
HMS3411K05
HMS3675K05
HMS3887K07
BCP12632
EX-A5415
HY-B0659
Tox21_110299
Tox21_501216
AC-162
NSC318825
PDSP1_000640
PDSP2_000635
s9508
AKOS005267239
Brimonidine;AGN190342;UK14304
Tox21_110299_1
CCG-205290
DB00484
FB19008
GS-3236
LP01216
NC00638
SDCCGSBI-0051183.P002
MRF-0000657
NCGC00016069-01
NCGC00016069-02
NCGC00016069-03
NCGC00016069-04
NCGC00016069-05
NCGC00016069-06
NCGC00016069-07
NCGC00016069-08
NCGC00016069-10
NCGC00016069-11
NCGC00016069-12
NCGC00016069-13
NCGC00016069-24
NCGC00023468-02
NCGC00023468-04
NCGC00023468-05
NCGC00023468-06
NCGC00023468-07
NCGC00261901-01
SY053060
Brimonidine 100 microg/mL in Acetonitrile
B4132
EU-0101216
NS00006954
EN300-50880
UK 14304-18
C07886
C75796
D07540
5-bromo-6-(2-imidazolidinylidenamino)quinoxaline
5-bromo-6-(2-imidazolin-2-ylamino) quinoxaline
5-Bromo-6-(2-imidazolin-2-ylamino)-quinoxaline
6-Quinoxalinamine,5-dihydro-1H-imidazol-2-yl)-
A832477
L000615
Q577377
SR-01000000023-2
SR-01000000023-4
BRD-K68264559-001-10-0
BRD-K68264559-001-13-4
BRD-K68264559-045-02-4
BRD-K68264559-045-03-2
BRD-K68264559-045-04-0
5-Bromo-N-(4,5-dihydro-2-imidazolyl)quinoxalin-6-amine
Z608061562
(5-Bromo-quinoxalin-6-yl)-(4,5-dihydro-1H-imidazol-2-yl)-amine
5-bromanyl-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine
5-BROMO-6-(2-IMIDAZOLIN-2-YLAMINO)QUINOXALINE D-TARTRATE (1:1).
6-Quinoxalinamine, 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)- (9CI)
5-Bromo-N-(4,5-dihydro-1H-imidazol-2-yl)-6-quinoxalinamine;5-Bromo-6-(2-imidazolin-2-ylamino)quinoxaline
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm